Phytic acid

DB14981InvestigationalSmall molecule

Phytic acid is under investigation in clinical trial NCT01000233 (Value of Oral Phytate (InsP6) in the Prevention of Progression of the Cardiovascular Calcifications).

Mechanism: Pharmacologically active on Intestinal-type alkaline phosphatase, Alkaline phosphatase, and Phosphatidylinositol 3-kinase
Curator reviewed
Formula / weight: C₆H₁₈O₂₄P₆ · 660.0353 g/mol (avg)
Also known as: Inositol hexaphosphate · myo-Inositol hexakisphosphate

Resolves to

Compound

UNII7IGF0S7R8ICAS83-86-3ChEMBLCHEMBL1233511ChEBI17401KEGGC01204

Clinical / RWD

RxNorm8302

Structure

InChIKeyIMQLKJBTEOYOSI-GPIVLXJGSA-NSMILESOP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O

Targets

P09923ALPI

What you can answer from here — as of July 07, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Phytic acid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account